ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

NIOSH To Fund 21 Projects With NCI Money

February 25, 1977

In Brief: Obey Fears Hangup On Abortion Funding will Kill Labor-Hew Appropriations Bill

July 6, 1979

In Brief: DeVita wins $150,000 Pezcoller Prize; BreastPac To “Storm” Capitol On Bastille Day For More $$

July 8, 1988

RFP Available; Program Announcement

April 16, 1993